https://www.prnewswire.com/il/news-releases/oramed-reaches-50-enrollment-in-phase-3-oral-insulin-study-301307702.html
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development...
in phaseoral insulinoramedreachesenrollment
https://www.prnewswire.com/news-releases/oramed-appoints-dr-arie-mayer-to-board-of-directors-300970023.html
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development...
board of directorsorameddrariemayer